Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
McKesson
Boehringer Ingelheim
Mallinckrodt
Colorcon

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Profile for Canada Patent: 2951627

See Plans and Pricing

« Back to Dashboard

US Patent Family Members and Drugs in Development for Canada Patent: 2951627

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Related US Patent Drugname Estimated Expiration
  Start Trial Fotemustine 2034-06-09
  Start Trial Napabucasin 2034-06-09
  Start Trial Tamibarotene 2034-06-09
  Start Trial Tegafur 2034-06-09
  Start Trial BBI608 2034-06-09
  Start Trial abraxane 2034-06-09
>Related US Patent >Drugname >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Express Scripts
Dow
McKesson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.